Invesco
CRDF icon

Invesco’s Cardiff Oncology CRDF Stock Holding History

Invesco’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,904
Closed -$33.9K – 3843
2026
Q1 		$33.9K Sell
20,904
-1,278
-6% -$2.63K ﹤0.01% 3717
2025
Q4 		$62.3K Sell
22,182
-3,100
-12% -$7.2K ﹤0.01% 3682
2025
Q3 		$52.1K Buy
25,282
+1,487
+6% +$4.11K ﹤0.01% 3747
2025
Q2 		$75K Buy
23,795
+4,749
+25% +$14.5K ﹤0.01% 3684
2025
Q1 		$59.8K Buy
19,046
+161
+0.9% +$637 ﹤0.01% 3684
2024
Q4 		$82K Buy
18,885
+1,080
+6% +$3.38K ﹤0.01% 3647
2024
Q3 		$47.5K Sell
17,805
-375
-2% -$886 ﹤0.01% 3694
2024
Q2 		$40.4K Buy
+18,180
New +$68.5K ﹤0.01% 3837
2022
Q2 		– Sell
-10,456
Closed -$26K – 4056
2022
Q1 		$26K Sell
10,456
-256
-2% -$905 ﹤0.01% 3974
2021
Q4 		$64K Sell
10,712
-5,709
-35% -$34K ﹤0.01% 3952
2021
Q3 		$110K Buy
16,421
+3,436
+26% +$21.6K ﹤0.01% 3921
2021
Q2 		$87K Buy
+12,985
New +$110K ﹤0.01% 3911
2020
Q4 		– Sell
-331,917
Closed -$4.71M – 3785
2020
Q3 		$4.71M Buy
+331,917
New +$2.19M ﹤0.01% 2038
2015
Q3 		– Sell
-7
Closed -$5K – 3827
2015
Q2 		$5K Buy
+7
New +$4.96K ﹤0.01% 4193

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Invesco's CRDF Position: Q2 2026 in Review

Invesco sold out of Cardiff Oncology (CRDF) in Q2 2026, closing a stake of 20,904 shares — an estimated $33.9K sold.

Invesco first reported a position in CRDF in Q2 2015 and held it in 14 quarters. The position peaked at $4.71M in Q3 2020. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Invesco reported no remaining Cardiff Oncology position as of Q2 2026 after selling out during the quarter.
  • Invesco sold 20,904 Cardiff Oncology shares in Q2 2026, an estimated $33.9K.
  • Invesco first reported a position in Cardiff Oncology in Q2 2015 and held it in 14 quarters.
  • Invesco's Cardiff Oncology position peaked at $4.71M in Q3 2020.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.